ArticleWorld journal of gastrointestinal surgery2025
Comparative clinical efficacy of three surgical modalities for the treatment of malignant tumours of the left hemicolon.
Article in World journal of gastrointestinal surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe advantages and disadvantages of various surgical procedures for radical dissection of left hemicolonic malignancies are controversial. We aimed to determine which procedures are best for patients with different characteristics. The focus of this study was to investigate the safety and clinical efficacy of three different surgical procedures, namely, robotic-assisted surgery (RAS), hand-assisted laparoscopic surgery (HALS) and conventional laparoscopic surgery (CLS), for the dissection of malignant tumors of the left hemicolon and the effect of these procedures on long-term prognosis.
aimTo determine which procedures are best for patients with malignant tumors of the left hemicolon and the safety and clinical efficacy of three different surgical procedures.
methodsA retrospective analysis of the clinical data of 224 patients with left hemicolonic malignancies admitted to the Department of General Surgery of the First Affiliated Hospital of Nanchang University from June 2015 to June 2024 was conducted. Patient data were analyzed to determine tumor stage, duration of surgery, number of lymph nodes cleared, incidence and severity of postoperative complications, amount of intraoperative bleeding, overall survival (OS), and progression-free survival.
resultsThe short-term postoperative outcomes after RAS, HALS and CLS were compared. The leukocyte and absolute neutrophil counts on postoperative day 4 were highest after RAS, followed by CLS and then HALS, and the differences were statistically significant (
conclusionThere were no significant differences between procedures in the number of lymph nodes cleared or OS, and all procedures successfully achieved radical dissection of the malignant tumors. HALS had lower hospitalization costs and shorter postoperative recovery time of gastrointestinal function, and CLS performed between HALS and RAS. Different surgical procedures have varying impacts on the length of postoperative hospital stay and the degree of postoperative inflammation, so selection should be individualized to each patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.